DHR - DANAHER CORP /DE/


181.52
-6.530   -3.597%

Share volume: 5,857,610
Last Updated: 03-27-2026
Measuring And Control Equipment/Industrial Measurement Instruments & Related Products: -0.04%

PREVIOUS CLOSE
CHG
CHG%

$188.05
-6.53
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
55%
Profitability 44%
Dept financing 43%
Liquidity 41%
Performance 72%
Company vs Stock growth
vs
Performance
5 Days
-4.51%
1 Month
-11.88%
3 Months
-21.29%
6 Months
-2.44%
1 Year
-11.45%
2 Year
-26.74%
Key data
Stock price
$181.52
P/E Ratio 
44.74
DAY RANGE
$181.01 - $186.00
EPS 
$5.07
52 WEEK RANGE
$171.00 - $242.80
52 WEEK CHANGE
-$11.45
MARKET CAP 
161.698 B
YIELD 
0.56%
SHARES OUTSTANDING 
707.139 M
DIVIDEND
$0.40
EX-DIVIDEND DATE
03-27-2026
NEXT EARNINGS DATE
07-22-2025
BETA 
0.56
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$4,457,264
AVERAGE 30 VOLUME 
$4,165,672
Company detail
CEO: Rainer M. Blair
Region: US
Website: danaher.com
Employees: 81,000
IPO year: 1987
Issue type: Common Stock
Market: NYSE
Industry: Measuring And Control Equipment/Industrial Measurement Instruments & Related Products
Sector: Manufacturing

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics.

Recent news